InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Xenon Pharmaceuticals Inc.

XENE Clue Score32
British Columbia, Canada Fiscal year ends December CIK 0001582313
$36.44 +0.77% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $36.44 +15.13% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue1.8Operating income−24.8Net income−23.0EPS, diluted−1.48Fiscal year 2017Revenue0.3 −82.8%Operating income−32.6Net income−30.7EPS, diluted−1.72Fiscal year 2018Operating income−38.0Net income−34.5EPS, diluted−1.63Fiscal year 2019Revenue6.8Operating income−42.8Net income−41.6Fiscal year 2020Revenue32.2 +371.0%Operating income−31.3Net income−28.8EPS, diluted−0.81Fiscal year 2021Revenue18.4 −42.7%Operating income−79.0Net income−78.9EPS, diluted−1.77Fiscal year 2022Revenue9.4 −48.8%Operating income−129.1Net income−125.4EPS, diluted−2.06Fiscal year 2023Revenue0.0 −100.0%Operating income−214.1Net income−182.4EPS, diluted−2.73Fiscal year 2024Revenue0.0Operating income−279.3Net income−234.3EPS, diluted−3.01Fiscal year 2025Revenue7.5Operating income−373.1Net income−345.9EPS, diluted−4.36
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 1.8 0.3 n/a 6.8 32.2 18.4 9.4 0.0 0.0 7.5
Growth −82.8% +371.0% −42.7% −48.8% −100.0%
Operating income −24.8 −32.6 −38.0 −42.8 −31.3 −79.0 −129.1 −214.1 −279.3 −373.1
Net income −23.0 −30.7 −34.5 −41.6 −28.8 −78.9 −125.4 −182.4 −234.3 −345.9
Growth
EPS, diluted −1.48 −1.72 −1.63 n/a −0.81 −1.77 −2.06 −2.73 −3.01 −4.36

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2016Operating margin−1,376.4%Net margin−1,275.5%Free cash flow margin−1,100.7%Fiscal year 2017Operating margin−10,474.3%Net margin−9,872.7%Free cash flow margin−9,337.9%Fiscal year 2018Fiscal year 2019Operating margin−627.0%Net margin−609.1%Free cash flow margin−87.2%Fiscal year 2020Operating margin−97.3%Net margin−89.7%Free cash flow margin−157.8%Fiscal year 2021Operating margin−428.4%Net margin−427.8%Free cash flow margin−388.1%Fiscal year 2022Operating margin−1,368.9%Net margin−1,328.9%Free cash flow margin−1,101.6%Fiscal year 2023Fiscal year 2024Fiscal year 2025Operating margin−4,974.3%Net margin−4,612.1%Free cash flow margin−3,732.2%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin −1,376.4% −10,474.3% n/a −627.0% −97.3% −428.4% −1,368.9% n/a n/a −4,974.3%
Net margin −1,275.5% −9,872.7% n/a −609.1% −89.7% −427.8% −1,328.9% n/a n/a −4,612.1%
Free cash flow margin −1,100.7% −9,337.9% n/a −87.2% −157.8% −388.1% −1,101.6% n/a n/a −3,732.2%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow−19.6Capital expenditure−0.3Free cash flow−19.8Fiscal year 2017Operating cash flow−28.7Capital expenditure−0.3Free cash flow−29.0Fiscal year 2018Operating cash flow−34.7Capital expenditure−0.5Free cash flow−35.2Fiscal year 2019Operating cash flow−4.7Capital expenditure−1.2Free cash flow−6.0Fiscal year 2020Operating cash flow−48.1Capital expenditure−2.6Free cash flow−50.8Fiscal year 2021Operating cash flow−69.5Capital expenditure−2.1Free cash flow−71.6Fiscal year 2022Operating cash flow−101.0Capital expenditure−2.9Free cash flow−103.9Fiscal year 2023Operating cash flow−151.1Capital expenditure−5.6Free cash flow−156.7Fiscal year 2024Operating cash flow−181.4Capital expenditure−3.1Free cash flow−184.5Fiscal year 2025Operating cash flow−279.1Capital expenditure−0.8Free cash flow−279.9
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −19.6 −28.7 −34.7 −4.7 −48.1 −69.5 −101.0 −151.1 −181.4 −279.1
Capital expenditure −0.3 −0.3 −0.5 −1.2 −2.6 −2.1 −2.9 −5.6 −3.1 −0.8
Free cash flow −19.8 −29.0 −35.2 −6.0 −50.8 −71.6 −103.9 −156.7 −184.5 −279.9
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2016Cash17.1Shareholders’ equity63.9Fiscal year 2017Cash20.5Total debt6.8Net cash (debt)13.7Shareholders’ equity35.9Debt to equity0.19Fiscal year 2018Cash67.8Total debt15.0Net cash (debt)52.7Shareholders’ equity103.3Debt to equity0.15Fiscal year 2019Cash24.8Total debt15.5Net cash (debt)9.2Shareholders’ equity92.0Debt to equity0.17Fiscal year 2020Cash45.0Shareholders’ equity171.4Fiscal year 2021Cash175.7Shareholders’ equity550.0Fiscal year 2022Cash57.2Shareholders’ equity721.5Fiscal year 2023Cash148.6Shareholders’ equity927.9Fiscal year 2024Cash142.7Shareholders’ equity754.9Fiscal year 2025Cash199.2Shareholders’ equity581.8
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 17.1 20.5 67.8 24.8 45.0 175.7 57.2 148.6 142.7 199.2
Total debt n/a 6.8 15.0 15.5 n/a n/a n/a n/a n/a n/a
Net cash (debt) n/a 13.7 52.7 9.2 n/a n/a n/a n/a n/a n/a
Shareholders’ equity 63.9 35.9 103.3 92.0 171.4 550.0 721.5 927.9 754.9 581.8
Debt to equity n/a 0.19 0.15 0.17 n/a n/a n/a n/a n/a n/a

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Cash flow

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020† 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Operations
−19.6 −28.7 −34.7 −4.7 −48.1 −69.5 −101.0 −151.1 −181.4 −279.1
Growth
Investment
−0.3 −0.3 −0.5 −1.2 −2.6 −2.1 −2.9 −5.6 −3.1 −0.8
calc −19.8 −29.0 −35.2 −6.0 −50.8 −71.6 −103.9 −156.7 −184.5 −279.9
Growth
calc −1.28 −1.61 −1.81 n/a −1.47 −1.64 −1.72 −2.34 −2.37 −3.53
n/a 24.3 −29.0 −66.2 −16.8 −246.8 −293.4 −111.4 165.0 218.0
Financing
n/a 7.1 111.6 27.5 85.8 447.5 278.5 353.5 12.1 117.1

† The diluted share count jumps at 2020, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Lines marked calc are worked out here from filed figures; point at one for how. Capital expenditure, dividends and buybacks are shown as money out, so negative.